Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK

被引:31
|
作者
McLernon, David J. [1 ]
Bond, Christine M.
Lee, Amanda J.
Watson, Margaret C.
Hannaford, Philip C.
Fortnum, Heather [2 ]
Krska, Janet [3 ]
Anderson, Claire [2 ]
Murphy, Elizabeth [4 ]
Avery, Anthony [2 ]
机构
[1] Univ Aberdeen, Med Stat Team, Sect Populat Hlth, Aberdeen AB25 2ZD, Scotland
[2] Univ Nottingham, Nottingham NG7 2RD, England
[3] Liverpool John Moores Univ, Liverpool L3 5UX, Merseyside, England
[4] Univ Leicester, Leicester, Leics, England
关键词
adverse drug reaction reporting system; patient; questionnaire; personal narratives; INFORMATION;
D O I
10.1002/pds.2117
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose To describe the characteristics of patient reporters to the UK's Yellow Card Scheme (YCS) and the suspect drugs reported, and to determine patient views and experiences of making a Yellow Card report. Methods A questionnaire was developed for distribution by the Medicines and Healthcare products Regulatory Agency (MHRA) to all patients reporting through the YCS between March 2008 and January 2009. Associations between reporting method (online, postal and telephone) and questionnaire responses were examined using Pearson's Chi-squared test. Results Evaluable questionnaires were returned by 1362 out of 2008 reporters (68%). Respondents' median (IQR) age was 56.5 (43.0, 67.0) years, 910 (66.8%) were female, 1274 (93.5%) were white and 923 (67.8%) had at least a further education qualification. The most frequent reporting method was postal (59.8%), followed by online (32.8%) and telephone (6.3%). Online reporters were younger with a higher education level than those using other reporting methods. Most respondents, 1274 (93.6%), thought that the report was fairly or very easy to complete, although many identified the need for improvements to the system. One third (n = 448; 32.9%) expected feedback from the MHRA and 828 (60.8%) would have liked feedback. Almost all respondents (n = 1302; 95.6%) would report again. Conclusions The majority of patients found the current methods of reporting suspected ADRs easy to use and would recommend them to others. Different methods of reporting were used by different demographic subgroups of reporters. Improvements to the system, including the provision of feedback to reporters, could be made. Copyright (C) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:523 / 531
页数:9
相关论文
共 50 条
  • [1] Identifying and managing adverse drug reactions: Qualitative analysis of patient reports to the UK yellow card scheme
    O'Donovan, Bernadine
    Rodgers, Ruth M.
    Cox, Anthony R.
    Krska, Janet
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (07) : 3434 - 3446
  • [3] Making medicines safer: analysis of patient reports to the UK's Yellow Card Scheme
    O'Donovan, B.
    Rodgers, Ruth M.
    Cox, Anthony R.
    Krska, Janet
    [J]. EXPERT OPINION ON DRUG SAFETY, 2019, 18 (12) : 1237 - 1243
  • [4] Analysis of UK Spontaneous Adverse Drug Reaction (ADR) Reports from the Yellow Card Scheme (YCS) from 2010 to 2014
    Harrison, K.
    Jan, T.
    Foy, M.
    [J]. DRUG SAFETY, 2015, 38 (10) : 986 - 987
  • [5] The Yellow Card Scheme: Experience of Patient Reporting of Adverse Drug Reaction Since Nationwide Launch
    Barrow, P. L.
    Foy, M.
    Gandhi, S.
    O'Keefe, V.
    King, C.
    Webb, R.
    [J]. DRUG SAFETY, 2009, 32 (10) : 968 - 968
  • [6] The Views of Reporters to the UK Yellow Card Scheme on the Importance of Direct Patient Reporting
    Krska, Janet
    Taylor, Julia
    Avery, Anthony J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S180 - S181
  • [7] Analysis of Spontaneous Adverse Drug Reaction (ADR) Reports from the Yellow Card Scheme (YCS) in 2010
    Jadeja, M. M.
    Surl, S.
    Foy, M.
    Gandhi, S.
    Cumber, S.
    [J]. DRUG SAFETY, 2011, 34 (10) : 1014 - 1014
  • [8] The yellow card scheme: Evaluation of patient reporting of suspected adverse drug reactions
    Ekins-Daukes, S.
    Irvine, D.
    Wise, L.
    Fiddes, S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S105 - S105
  • [9] Adverse Drug Reaction Reporting in the UK A Retrospective Observational Comparison of Yellow Card Reports Submitted by Patients and Healthcare Professionals
    McLernon, David J.
    Bond, Christine M.
    Hannaford, Philip C.
    Watson, Margaret C.
    Lee, Amanda J.
    Hazell, Lorna
    Avery, Anthony
    [J]. DRUG SAFETY, 2010, 33 (09) : 775 - 788
  • [10] How Patient Reporters Identify Adverse Drug ReactionsA Qualitative Study of Reporting via the UK Yellow Card Scheme
    Janet Krska
    Claire Anderson
    Elizabeth Murphy
    Anthony J. Avery
    [J]. Drug Safety, 2011, 34 : 429 - 436